Evidence map›Paper›PMID 42254832›Full record

ArticleNeuro-oncology advances

Intraoperative, interstitial brachytherapy in newly diagnosed brain metastases through cesium-131 collagen tile implant: A multi-institutional case series.

Carlin Chuck, Mazen Taman, Trenton Kite, Alice Lin, Natalie Amaral-Nieves, Elaina Wang, Joseph Oldam, Abigail A Teshome, Hsien-Chung Chen, Rohil Shekher and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Carlin ChuckDepartment of Neurosurgery, Warren Alpert School of Medicine, Rhode Island Hospital, Brown University, Providence, RI, USA.
Mazen TamanDepartment of Neurosurgery, Warren Alpert School of Medicine, Rhode Island Hospital, Brown University, Providence, RI, USA.ORCID https://orcid.org/0009-0000-8133-6929
Trenton KiteDepartment of Neurosurgery, Allegheny Health Network Neuroscience Institute, Pittsburgh, PA, USA.
Alice LinDepartment of Neurosurgery, Warren Alpert School of Medicine, Rhode Island Hospital, Brown University, Providence, RI, USA.
Natalie Amaral-NievesDepartment of Neurosurgery, Warren Alpert School of Medicine, Rhode Island Hospital, Brown University, Providence, RI, USA.
Elaina WangDepartment of Neurosurgery, Warren Alpert School of Medicine, Rhode Island Hospital, Brown University, Providence, RI, USA.
Joseph OldamDepartment of Neurosurgery, Warren Alpert School of Medicine, Rhode Island Hospital, Brown University, Providence, RI, USA.
Abigail A TeshomeDepartment of Neurosurgery, Warren Alpert School of Medicine, Rhode Island Hospital, Brown University, Providence, RI, USA.
Hsien-Chung Chen
Rohil ShekherDepartment of Radiation Oncology, Westchester Medical Center, Valhalla, NY, USA.
Sabrina ZellerDepartment of Neurosurgery, Westchester Medical Center, Valhalla, NY, USA.
Heinrich ElinzanoDepartment of Neurology, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Sasmit SarangiDepartment of Neurology, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Eric T WongDepartment of Neurology, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Mark RivardDepartment of Radiation Oncology, Warren Alpert School of Medicine, Rhode Island Hospital, Brown University, Providence, RI, USA.
Clara FerreiraDepartment of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA.
Simon HanftDepartment of Neurosurgery, Westchester Medical Center, Valhalla, NY, USA.
Clark C ChenDepartment of Neurosurgery, Warren Alpert School of Medicine, Rhode Island Hospital, Brown University, Providence, RI, USA.ORCID https://orcid.org/0000-0001-9544-2570

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cesium-131 collagen tile has gained traction as an intraoperative brachytherapy platform for recurrent intracranial tumors, but outcome data in newly diagnosed brain metastases (nBM) remain sparse, with fewer than ten cases reported. This study evaluates the safety and efficacy of cesium-131 collagen tiles in nBM patients. Methods: Clinical information was collected for consecutive nBM patients treated at three neurosurgical centers. Local control and overall survival (OS) were calculated. Results: The cohort comprised 36 patients (14 men, 22 women; mean age, 62.1 ± 8.9 years) with 39 nBM. Histologies included lung ( Conclusion: This multi-institutional study provides the first dedicated evaluation of cesium-131 collagen tiles for the treatment of nBM, demonstrating excellent safety and local control.

Indexed as

brain metastasescesium-131collagen tile implantintraoperative brachytherapylocal control

Identifiers

PMID42254832
PMCPMC13242292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.